Concourse Financial Group Securities’s XTL Biopharmaceuticals XTLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 8591 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 8676 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 8681 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 8691 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 8693 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 8625 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 8414 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 8202 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 7899 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7910 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7736 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7619 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 7479 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 7349 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7103 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6843 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6597 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 6399 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6187 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6031 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 5949 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 5867 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 5712 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 5732 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 5632 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5548 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5386 |
|